TrialNature communications2026
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study.
Nina Hertoghs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it